METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS
Clinical trials for METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS trials appear
Sign up with your email to follow new studies for METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune weapon tested against advanced prostate cancer
Disease control Recruiting nowThis early-stage study is testing a new drug, JNJ-78278343, that aims to guide the body's own immune cells to attack prostate cancer. It is being given in combination with other standard treatments like immunotherapy, chemotherapy, or hormone therapy. The main goals are to find a…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New hope for tough prostate cancer: can this drug help men live longer?
Disease control Recruiting nowThis study is testing if an experimental drug called pasritamig, when added to standard supportive care, helps men with advanced prostate cancer live longer compared to supportive care alone. It will involve about 663 men whose cancer has spread and is no longer responding to sta…
Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC